ADA Scientific Sessions 2026 Abstract

Preclinical Proof of Concept of ZT009, a Novel Unimolecular Long-Acting GLP-1 and Amylin Receptor Agonist

By Yuying Zhang, Bo Wu, Baochang Zhang, Yuanyuan Zhang

Experiments in animalsInterventions

The paper

Yuying Zhang, Bo Wu, Baochang Zhang, Yuanyuan Zhang

Beijing

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 2552-P

doi.org/10.2337/db26-2552-p

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes